By working with researchers and industry we develop, apply and test precision medicine strategies based on genomic sequencing data.
Home of the Glasgow Cancer Assays, the Glasgow Precision Oncology Laboratory‘s purpose-built facilities, expertise and resources are aligned to maximise the speed of development of novel precision strategies in oncology.
GPOL will provide genomic sequencing for the University of Glasgow-led PREDICT-Meso (Pre-malignant drivers combined with target-drug validation in mesothelioma), a new £5 million mesothelioma project…
Our researchers are working on cancer science that really matters in the real world.
The GPOL is a purpose-built molecular profiling unit specifically designed to address the needs for large-scale discovery alongside the development, and delivery, of clinically relevant assays.
GPOL supports clinical trials, scientific research and precision medicine delivery.
Precision medicine requires the integration of a molecular pathology driven approach throughout the therapeutic development cycle.